1. Home
  2. MLCI vs IXHL Comparison

MLCI vs IXHL Comparison

Compare MLCI & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLCI

Mount Logan Capital Inc.

HOLD

Current Price

$2.78

Market Cap

31.3M

Sector

Finance

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.56

Market Cap

37.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLCI
IXHL
Founded
N/A
2001
Country
United States
Australia
Employees
21
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
37.0M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
MLCI
IXHL
Price
$2.78
$3.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.0K
263.6K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
2.63%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.68
$0.16
52 Week High
$8.68
$6.39

Technical Indicators

Market Signals
Indicator
MLCI
IXHL
Relative Strength Index (RSI) 33.45 48.30
Support Level $2.68 $2.68
Resistance Level $3.13 $3.68
Average True Range (ATR) 0.18 0.36
MACD 0.02 0.04
Stochastic Oscillator 15.90 54.48

Price Performance

Historical Comparison
MLCI
IXHL

About MLCI Mount Logan Capital Inc.

Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The company's reporting segments include asset management and insurance. The company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The Asset Management segment comprises all fee generating activities. The Insurance Solutions segment, which derives maximum revenue, consists of two product lines within the insurance business, LTC and MYGA.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: